Close
Close
Treatment Database
N-[2,6-bis(1-methylethyl)phenyl]-N'-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]urea, hydrochloride salt
Trade Name not avaiable
Orphan Indication Congenital adrenal hyperplasia
USA Market Approval
USA Designation Date 17-08-2017
Sponsor Millendo Therapeutics, Inc.
301 North Main Street, Suite 100
Ann Arbor, Michigan, 48104
More about Congenital adrenal hyperplasia
Free Newsletter
Videos
by Abidemi Uruejoma
13 views
by Abidemi Uruejoma
32 views
by Abidemi Uruejoma
50 views